HER2 analysis in breast cancer: Reduced immunoreactivity in FISH non-informative cancer biopsies

  • Authors: Coya Tapia, Peter Schraml, Ronald Simon, Khawla S. Al-Kuraya, Robert Maurer, Martina Mirlacher, Hedvika Novotny, Hanspeter Spichtin, Michael J. Mihatsch, Guido Sauter
  • View Affiliations

  • Published online on: Wednesday, December 1, 2004
  • Pages: 1551-1557
  • DOI: 10.3892/ijo.25.6.1551

Abstract

Due to the central role in predicting response to herceptin and possibly also other anticancer drugs, accurate and reproducible detection of the HER2 status is important. Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) are the most commonly used methods for HER2 analysis. It is a disadvantage of FISH that a fraction of cases remain not interpretable probably due to suboptimal tissue handling before analysis. To investigate a possible influence of tissue damage on the results of HER2 IHC we compared the HER2 IHC results obtained in tumors with and without interpretable FISH in a breast cancer tissue microarray. The HER2 IHC results differed greatly between 1551 tumors with interpretable HER2 FISH signals and 405 breast cancers showing no FISH signals. FISH informative tumors had an IHC score of 3+ in 12.6%, 2+ in 3% and 1+ in 9.2% of cases. FISH non-informative tumors showed significantly lower IHC scores (p<0.0001). They were IHC 3+ in 3.9%, 2+ in 3.7% and 1+ in 4.4% of cases. Overall, the data show that not only FISH but also IHC results are dependent on good tissue quality for successful analysis. Poor tissue quality can be easily identified in FISH analyses because of a lack of hybridization signals. Inappropriate tissue handling is more dangerous in IHC because an artificial lack of staining can be regarded as ‘negative’ result.
Journal Cover

December 2004
Volume 25 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

2013 Impact Factor: 2.773
Ranked #30/202 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Tapia, C., Schraml, P., Simon, R., Al-Kuraya, K., Maurer, R., Mirlacher, M., Novotny, H., Spichtin, H., Mihatsch, M., & Sauter, G. (2004). HER2 analysis in breast cancer: Reduced immunoreactivity in FISH non-informative cancer biopsies. International Journal of Oncology, 25(6), 1551-1557.
MLA
Tapia, Schraml, Simon, Al-Kuraya, Maurer, Mirlacher, Novotny, Spichtin, Mihatsch, and Guido Sauter. "HER2 analysis in breast cancer: Reduced immunoreactivity in FISH non-informative cancer biopsies." International Journal of Oncology International Journal of Oncology 25.6 (2004): 1551-1557.
Chicago
Tapia, Schraml, Simon, Al-Kuraya, Maurer, Mirlacher, Novotny, Spichtin, Mihatsch, and Guido Sauter. "HER2 analysis in breast cancer: Reduced immunoreactivity in FISH non-informative cancer biopsies." International Journal of Oncology International Journal of Oncology 25 no. 6 (2004): 1551-1557.